サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1575037

ファンクショナルサービスプロバイダー (FSP)市場：タイプ別、疾患タイプ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Functional Service Providers (FSP) Market, By Type, By Disease Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 284 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.85円
ファンクショナルサービスプロバイダー (FSP)市場：タイプ別、疾患タイプ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 284 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

ファンクショナルサービスプロバイダー（FSP）市場規模は2023年に147億3,043万米ドルとなり、2024年から2032年にかけてCAGR 8.30%で拡大

ファンクショナルサービスプロバイダー（FSP）市場-市場力学

臨床試験やヘルスケア分野でのアウトソーシング需要の高まりが市場需要を促進する見込み

ヘルスケア企業は、主要な事業目標に集中し、運営コストを削減し、効率を高めるために、非中核機能をFSPにアウトソーシングする傾向が強まっています。臨床試験がより複雑化し世界化する中、FSPは規制要件やロジスティクスの課題を解決するための専門知識やリソースを提供しています。また、人工知能、ビッグデータ分析、デジタルヘルス・ソリューションなどの先端技術の統合は、FSPの能力を高め、そのサービスを顧客にとってより魅力的なものにしています。

FSPはまた、専門知識、確立されたプロセス、テクノロジーを活用することで、費用対効果の高いソリューションを提供し、顧客組織は運営コストを削減することができます。患者中心のケアモデルと個別化医療へのシフトは、オーダーメイドの臨床開発と患者エンゲージメント戦略をサポートできるFSPの採用を後押ししています。さらに、製薬会社やバイオテクノロジー企業による研究開発への投資が拡大していることも、医薬品開発を促進し、新しい治療法を市場に投入するためのFSPサービスへの需要を後押ししています。

ファンクショナルサービスプロバイダー市場-主要な洞察

リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約8.30%のCAGRで毎年成長すると予測されています。

タイプ別では、臨床試験からFSPへの高い需要のため、臨床試験デザイン＆モニタリングセグメントが2023年に最大の市場シェアを示すと予測されました。

疾患タイプ別では、製薬企業とバイオテクノロジー企業間の提携が増加していることから、2023年の主要疾患タイプはオンコロジー分野でした。

エンドユーザー別では、研究支出と機能的サービスの利用が増加していることから、バイオ製薬企業が2023年の主要エンドユーザーでした。

地域別では、医療業界における先端技術の存在により、北米が2023年の主要収益源でした。

ファンクショナルサービスプロバイダー（FSP）市場-セグメンテーション分析：

世界のファンクショナルサービスプロバイダー（FSP）市場は、タイプ、疾患タイプ、エンドユーザー、地域に基づいてセグメント化されます。

タイプ別では、臨床試験デザイン＆モニタリング、データマネジメント、ファーマコビジランス、メディカルライティング、その他の5つに分類されます。臨床試験デザイン＆モニタリング分野が市場を独占しています。リアルタイム管理における技術導入とモニタリングの利点が市場成長を支えています。

市場は疾患タイプ別では、がん、感染症、心血管疾患、神経疾患、免疫学、その他の6つに分類されます。オンコロジー分野は市場を独占しています。CROやバイオファーマ企業は、泌尿器科や血液疾患の専門知識を得るための研究に投資しており、これが同分野の需要を押し上げています。

市場はエンドユーザー別にバイオ製薬企業、CRO、その他の3つに分類されます。バイオ製薬企業が市場を独占しており、予測期間中も高い優位性を維持するとみられます。スポンサーとFSPの協業戦略が活発化し、臨床開発への統合的アプローチが高まっています。

ファンクショナルサービスプロバイダー（FSP）市場-地理的洞察

地域的には、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。北米、特に米国は、製薬会社やバイオテクノロジー企業が集中し、臨床研究や医薬品開発に多額の投資を行っていることから、FSPサービスの最大市場となっています。欧州もFSPサービスの有力市場であり、臨床研究に対する政府の強力な支援、多くのバイオテクノロジー企業、複雑な規制環境がその原動力となっています。アジア太平洋地域は、臨床試験件数の増加、運営コストの低下により、FSP市場が急成長しています。

ファンクショナルサービスプロバイダー（FSP）市場-競合情勢：

ファンクショナルサービスプロバイダー（FSP）市場は競争が激しく、製薬、バイオテクノロジー、臨床研究機関に専門サービスを提供する多様な企業が存在します。各社はFSPサービスを強化するため、テクノロジーに多額の投資を行っています。これには、人工知能、ビッグデータ分析、クラウドベースのプラットフォームを活用して、臨床試験業務、データ管理、患者募集を最適化することが含まれます。FSPプロバイダーは、アジア太平洋（中国、インド）、ラテンアメリカ、東欧などの新興市場で拡大する臨床研究活動に参入するため、地理的な足跡を拡大しています。この拡大により、より広範な患者プールへのアクセスとコスト効率の高いソリューションが可能になります。

2023年1月、Premier ResearchとCentogene N.V.が臨床試験におけるエンドツーエンドのサポートを提供するために提携。

2022年12月、生物統計学で高い経験を持つエベレスト・クリニカル・リサーチが、事業拡大のためブライトテック・インターナショナルを買収。

目次

第1章 ファンクショナルサービスプロバイダー (FSP)市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ファンクショナルサービスプロバイダー（FSP）の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ファンクショナルサービスプロバイダー（FSP）業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 ファンクショナルサービスプロバイダー（FSP）市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 ファンクショナルサービスプロバイダー（FSP）市場情勢

  • ファンクショナルサービスプロバイダー市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ファンクショナルサービスプロバイダー（FSP）市場- タイプ別

  • 概要
    • タイプ別セグメントシェア分析
    • 臨床試験の設計とモニタリング
    • データ管理
    • 医薬品安全性監視
    • 医学論文執筆
    • その他

第8章 ファンクショナルサービスプロバイダー（FSP）市場- 疾病タイプ別

  • 概要
    • 疾病タイプ別セグメントシェア分析
    • 腫瘍学
    • 感染症
    • 心血管疾患
    • 神経疾患
    • 免疫学
    • その他

第9章 ファンクショナルサービスプロバイダー（FSP）市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • バイオ医薬品企業
    • CRO
    • その他

第10章 ファンクショナルサービスプロバイダー（FSP）市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- ファンクショナルサービスプロバイダー（FSP）業界

  • 競合ダッシュボード
  • 企業プロファイル
    • IQVIA
    • Labcorp Drug Development
    • Parexel
    • ICON plc
    • Everest Clinical Research
    • Thermo Fisher Scientific
    • Syneos Health
    • Medpace
    • Charles River Laboratories
    • KCR
    • Worldwide Clinical Trials
    • Veristat
    • Celerion
    • Pharm-Olam
    • Premier Research
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV4035

REPORT HIGHLIGHT

Functional Service Providers (FSP) Market size was valued at USD 14,730.43 Million in 2023, expanding at a CAGR of 8.30% from 2024 to 2032.

A Functional Service Provider (FSP) is a type of outsourcing model commonly used in the pharmaceutical and clinical research industries. Under this model, companies like pharmaceutical firms, biotechnology companies, and clinical research organizations (CROs) outsource specific functions or activities to a third-party service provider.

Functional Service Providers (FSP) Market- Market Dynamics

Rising demand for outsourcing in clinical trials and healthcare sector is expected to propel market demand

Healthcare companies are increasingly outsourcing non-core functions to FSPs to focus on their primary business objectives, reduce operational costs, and enhance efficiency. As clinical trials become more complex and globalized, FSPs offer expertise and resources that help navigate regulatory requirements and logistical challenges. Also, the integration of advanced technologies, such as artificial intelligence, big data analytics, and digital health solutions, enhances the capabilities of FSPs, making their services more attractive to clients.

FSPs also provide cost-effective solutions by leveraging their expertise, established processes, and technologies, allowing client organizations to save on operational costs. The shift toward patient-centric care models and personalized medicine encourages the adoption of FSPs that can support tailored clinical development and patient engagement strategies. In addition, growing investments in research and development by pharmaceutical and biotech companies drive the demand for FSP services to facilitate drug development and bring new therapies to market.

Functional Service Providers (FSP) Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.30% over the forecast period (2024-2032)

Based on Type segmentation, the clinical trial design & monitoring segment was predicted to show maximum market share in the year 2023, owing to high demand for FSP from clinical trials.

Based on Disease Type segmentation, oncology segment was the leading Disease Type segment in 2023, due to the rising partnerships between pharma & biotech companies.

Based on End User segmentation, biopharmaceutical companies segment was the leading End User segment in 2023, due to the increasing research spending & use of functional services.

On the basis of region, North America was the leading revenue generator in 2023, due to the presence of advanced tech in the medical industry.

Functional Service Providers (FSP) Market- Segmentation Analysis:

Global Functional Service Providers (FSP) Market is segmented on the basis of Type, Disease Type, End User, and Region.

The market is divided into five categories based on Type: clinical trial design & monitoring, data management, pharmacovigilance, medical writing, and others. The clinical trial design & monitoring segment dominates the market. Technology adoption & monitoring benefits in real time management is supporting market growth.

The market is divided into six categories based on Disease Type: oncology, infectious diseases, cardiovascular diseases, neurological diseases, immunology, and others. The oncology segment dominates the market. CROs and biopharma companies investing in research to expertise in urology, hematology disorders which is boosting segment demand.

The market is divided into three categories based on End User: biopharmaceutical companies, CROs, and others. The biopharmaceutical companies segment dominates the market and is expected to maintain its high dominance during the forecast period. Increasing collaborative strategy between sponsors and FSPs is raising integrated approach to clinical development.

Functional Service Providers (FSP) Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, especially the United States, is the largest market for FSP services due to the high concentration of pharmaceutical and biotechnology companies, as well as significant investments in clinical research and drug development. Europe is another prominent market for FSP services, driven by strong government support for clinical research, many biotechnology firms, and a complex regulatory environment. The Asia-Pacific region is experiencing rapid growth in the FSP market, fueled by the increasing number of clinical trials, lower operational costs.

Functional Service Providers (FSP) Market- Competitive Landscape:

The Functional Service Provider (FSP) market is highly competitive, with a diverse set of companies offering specialized services to pharmaceutical, biotechnology, and clinical research organizations. Companies are investing heavily in technology to enhance their FSP offerings. This includes leveraging artificial intelligence, big data analytics, and cloud-based platforms to optimize clinical trial operations, data management, and patient recruitment. FSP providers are expanding their geographic footprint to tap into the growing clinical research activity in emerging markets such as Asia-Pacific (China, India), Latin America, and Eastern Europe. This expansion enables access to a broader patient pool and cost-effective solutions.

In January 2023, Premier Research and Centogene N.V. collaborated to offer end-to-end support in clinical trials.

In December 2022, Everest Clinical Research with high experience in biostatistics acquired Brightech International to expand their business.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET KEY PLAYERS

  • IQVIA
  • Labcorp Drug Development
  • Parexel
  • ICON plc
  • Everest Clinical Research
  • Thermo Fisher Scientific
  • Syneos Health
  • Medpace
  • Charles River Laboratories
  • KCR
  • Worldwide Clinical Trials
  • Veristat
  • Celerion
  • Pharm-Olam
  • Premier Research
  • Others

GLOBAL FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Clinical trial design & monitoring
  • Data management
  • Pharmacovigilance
  • Medical writing
  • Others

GLOBAL FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Oncology
  • Infectious diseases
  • Cardiovascular diseases
  • Neurological diseases
  • Immunology
  • Others

GLOBAL FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Biopharmaceutical Companies
  • CROs
  • Others

GLOBAL FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Functional Service Providers (FSP) Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Functional Service Providers (FSP) Market Snippet by Type
    • 2.1.2. Functional Service Providers (FSP) Market Snippet by Disease Type
    • 2.1.3. Functional Service Providers (FSP) Market Snippet by End User
    • 2.1.4. Functional Service Providers (FSP) Market Snippet by Country
    • 2.1.5. Functional Service Providers (FSP) Market Snippet by Region
  • 2.2. Competitive Insights

3. Functional Service Providers (FSP) Key Market Trends

  • 3.1. Functional Service Providers (FSP) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Functional Service Providers (FSP) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Functional Service Providers (FSP) Market Opportunities
  • 3.4. Functional Service Providers (FSP) Market Future Trends

4. Functional Service Providers (FSP) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Functional Service Providers (FSP) Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Functional Service Providers (FSP) Market Landscape

  • 6.1. Functional Service Providers (FSP) Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Functional Service Providers (FSP) Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Clinical trial design & monitoring
    • 7.1.3. Data management
    • 7.1.4. Pharmacovigilance
    • 7.1.5. Medical writing
    • 7.1.6. Others

8. Functional Service Providers (FSP) Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 8.1.2. Oncology
    • 8.1.3. Infectious diseases
    • 8.1.4. Cardiovascular diseases
    • 8.1.5. Neurological diseases
    • 8.1.6. Immunology
    • 8.1.7. Others

9. Functional Service Providers (FSP) Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Biopharmaceutical Companies
    • 9.1.3. CROs
    • 9.1.4. Others

10. Functional Service Providers (FSP) Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Functional Service Providers (FSP) Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Functional Service Providers (FSP) Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Functional Service Providers (FSP) Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Functional Service Providers (FSP) Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Functional Service Providers (FSP) Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Functional Service Providers (FSP) Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. IQVIA
    • 11.2.2. Labcorp Drug Development
    • 11.2.3. Parexel
    • 11.2.4. ICON plc
    • 11.2.5. Everest Clinical Research
    • 11.2.6. Thermo Fisher Scientific
    • 11.2.7. Syneos Health
    • 11.2.8. Medpace
    • 11.2.9. Charles River Laboratories
    • 11.2.10. KCR
    • 11.2.11. Worldwide Clinical Trials
    • 11.2.12. Veristat
    • 11.2.13. Celerion
    • 11.2.14. Pharm-Olam
    • 11.2.15. Premier Research
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us